Balanol is a potent ATP-competitive inhibitor of PKC/PKA, inhibiting human PKC isoforms α, β-I, β-II, γ, δ, ε, and η (IC50 = 4–9 nM) as well as ζ (IC50 = 150 nM); it also blocks the phosphorylation of cAMP response element-binding protein (CREB) and myristoylated alanine-rich C-kinase substrate (MARCKS).